Development of Potent Pf CLK3 Inhibitors Based on TCMDC-135051 as a New Class of Antimalarials (2020)

First Author: Mahindra A

Attributed to: Translational Research Initiative funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1021/acs.jmedchem.0c00451

PubMed Identifier: 32787140

Publication URI: http://europepmc.org/abstract/MED/32787140

Type: Journal Article/Review

Parent Publication: Journal of Medicinal Chemistry

Issue: 17

ISSN: 0022-2623